World Health Organization Says COVID-19 Is No Longer a Global Emergency

GENEVA (AP) — The World Health Organization said Friday that COVID-19 no longer qualifies as a global emergency, marking a symbolic end to the devastating coronavirus pandemic that triggered once-unthinkable lockdowns, upended economies worldwide and killed at least 7 million people worldwide. WHO said that even though the emergency phase was over, the pandemic hasn’t … Read more

Quiz: Is Your Work Stress Burnout?

Christina Maslach is professor emerita of psychology at the University of California, Berkeley, and Michael P. Leiter is professor emeritus of psychology at Acadia University. Maslach and Leiter co-authored The Burnout Challenge: Managing People’s Relationships with Their Jobs. If you’re like roughly 40% of office workers, you might describe yourself as feeling burned out by … Read more

COVID-19 Vaccines Aren’t Strongly Linked to Menstrual Changes, Study Says

While the COVID-19 vaccines have made a dramatic difference in controlling the pandemic, researchers are still learning about the ways that the shots may affect people’s health. One of those questions centers around how the vaccines might impact menstrual cycles. Reports of women experiencing changes in their cycles—either in the intensity and frequency of bleeding, … Read more

To Make a Real Difference in Health Care, AI Will Need to Learn Like We Do

Millions of people, many of whom have never thought much about computer science, are experimenting with generative AI models such as the eminently conversational ChatGPT and creative image generator DALL-E. While these products reflect less of a technological breakthrough than AI’s emergence into the public consciousness, the traction they have found is guiding massive investment … Read more

Why It Took So Long to Finally Get an RSV Vaccine

Respiratory syncytial virus (RSV) can dangerously compromise breathing, especially for infants and the elderly. But there has been no vaccine to prevent it—until today. On May 3, the U.S. Food and Drug Administration (FDA) approved the first vaccine against RSV, from GlaxoSmithKline (GSK), to prevent respiratory disease in people ages 60 and older. The Centers … Read more

Eli Lilly’s Alzheimer’s Drug Shows Greatest Benefit Yet

In a May 3 press release, Eli Lilly announced encouraging results from its latest study of its Alzheimer’s drug candidate, donanemab. In the Phase 3 study, which included more than 1,000 people with early signs of Alzheimer’s disease, people receiving donanemab experienced 35% slower cognitive decline, as measured on cognitive tests, than people receiving placebo. … Read more